Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin lock for prevention of catheter-related bloodstream infection in HSCT patients
IRCT20100127003210N18Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2019
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vancomycin in catheter-associated bloodstream infection (CRBSI) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Catheter related bloodstream infection. Started Nov 2019; status: completed.
02
Drugs
vancomycin
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on IRCT20100127003210N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N18.